(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of -2.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.25%.
Xtant Medical Holdings's revenue in 2025 is $133,083,000.On average, 4 Wall Street analysts forecast XTNT's revenue for 2025 to be $19,036,376,513, with the lowest XTNT revenue forecast at $18,262,153,066, and the highest XTNT revenue forecast at $19,625,794,363. On average, 4 Wall Street analysts forecast XTNT's revenue for 2026 to be $16,194,290,441, with the lowest XTNT revenue forecast at $13,953,662,584, and the highest XTNT revenue forecast at $18,390,956,966.
In 2027, XTNT is forecast to generate $17,672,735,215 in revenue, with the lowest revenue forecast at $15,215,660,803 and the highest revenue forecast at $20,080,808,143.